Article Text

Download PDFPDF
Pragmatic approach to muscle MRI biomarkers in motor neuron disease
  1. Neil G Simon
  1. Correspondence to Dr Neil G Simon, St Vincent’s Clinical School, University of New South Wales, Darlinghurst, New South Wales, Australia; n.simon{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

A rapid whole body muscle MRI protocol is sensitive to disease progression in motor neuron disease.

As part of the evolution of neuromuscular medicine, there has been a move towards tools that can objectively measure change in the disease without relying on relatively insensitive or subjective clinical measures. Motor neuron disease (MND) has a wide array of potential clinical phenotypes and disease progression can be unpredictable between individuals.1 Clinical instruments to measure MND have well-defined limitations.2 3 For these reasons, it is necessary to develop objective non-clinical measures of disease progression in MND.

In their JNNP paper, Dr Jenkins and colleagues have advanced muscle MRI as a potential biomarker of MND progression.4 The authors performed whole body T2-weighted imaging on a cohort of patients with MND and demonstrated an …

View Full Text


  • Contributors NGS wrote this editorial without other contributors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Neuromuscular
    Thomas M Jenkins James J P Alix Charlotte David Eilish Pearson D Ganesh Rao Nigel Hoggard Eoghan O’Brien Kathleen Baster Michael Bradburn Julia Bigley Christopher J McDermott Iain D Wilkinson Pamela J Shaw